Scientific Sessions 2025  /  Hottest Clinical Trials in Valvular Heart Disease: Key Insights from Late-Breaking Studies  /  TAVR vs. SAVR in Low-Risk Aortic Stenosis Patients: 5-Year Outcomes Unveiled for Evolut Low-Risk
Logo

American Heart Association

  37
  0

Final ID:

TAVR vs. SAVR in Low-Risk Aortic Stenosis Patients: 5-Year Outcomes Unveiled for Evolut Low-Risk

  • Reardon, Michael  ( Houston Methodist Hospital , Houston , Texas , United States )
  • Forrest, John  ( Yale University , Hamden , Connecticut , United States )
  • Popma, Jeffrey  ( Beth Israel Deaconess Medical Cente , BOSTON , Massachusetts , United States )
  • Tchetche, Didier  ( CLINIQUE PASTEUR TOULOUSE , TOULOUSE , France )
    • Author Disclosures:
    Michael Reardon: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Speaker:Siemens:Active (exists now) ; Speaker:Medtronic:Active (exists now) ; Speaker:BSCI:Active (exists now) ; Speaker:W. L. Gore and Associates, Inc.:Active (exists now) ; Advisor:J Valve:Active (exists now) ; Advisor:High Life:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Advisor:W. L. Gore and Associates, Inc.:Active (exists now) ; Advisor:BSCI:Active (exists now) ; Consultant:BSCI:Active (exists now) ; Consultant:Siemens:Active (exists now) ; Consultant:W. L. Gore and Associates, Inc.:Active (exists now) | John Forrest: DO have relevant financial relationships ; Research Funding (PI or named investigator):Medtronic Inc:Active (exists now) ; Consultant:Edwards Lifesciences:Active (exists now) ; Consultant:Medtronic Inc:Active (exists now) ; Research Funding (PI or named investigator):Edwards Lifesciences:Active (exists now) | Jeffrey Popma: No Answer | DIDIER TCHETCHE: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Hottest Clinical Trials in Valvular Heart Disease: Key Insights from Late-Breaking Studies

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Early TAVR Trial: Latest Updates of Early TAVR in Severe Asymptomatic Aortic Stenosis Patients

Genereux Philippe, Leon Martin, Mack Michael, Hahn Rebecca

Valvular Heart Disease Clinical Trials: What Does the Future Hold?

Enriquez-sarano Maurice, Mack Michael, Ogara Patrick, Leon Martin

More abstracts from these authors:
TAVR for All Patients

Hahn Rebecca, Genereux Philippe, Makkar Raj, Mehran Roxana, Tchetche Didier, Webb John

The SMART Trial: Balloon-Expandable vs Self-Expanding TAVR in Women with Small Annuli

Mehran Roxana, Tchetche Didier, Guerrero Mayra E, Herrmann Howard

You have to be authorized to contact abstract author. Please, Login
Not Available